Private Capital Group’s Charles River Laboratories CRL Stock Holding History

Private Capital Group’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$21K	Hold	97	–	–	0.02%	807
2022 Q1	$28K	Buy	97 +4	+4%	+$1.23K	0.01%	888
2021 Q4	$35K	Hold	93	–	–	0.01%	826
2021 Q3	$38K	Hold	93	–	–	0.01%	789
2021 Q2	$34K	Buy	93 +2	+2%	+$668	0.01%	825
2021 Q1	$26K	Sell	91 -89	-49%	-$24.7K	0.01%	921
2020 Q4	$45K	Hold	180	–	–	0.01%	843
2020 Q3	$41K	Buy	180 +20	+13%	+$4.15K	0.01%	812
2020 Q2	$28K	Buy	160 +43	+37%	+$6.86K	0.01%	968
2020 Q1	$15K	Hold	117	–	–	﹤0.01%	1134
2019 Q4	$17K	Hold	117	–	–	﹤0.01%	1159
2019 Q3	$16K	Hold	117	–	–	﹤0.01%	1276
2019 Q2	$13K	Hold	117	–	–	﹤0.01%	1265
2019 Q1	$17K	Hold	117	–	–	﹤0.01%	1269
2018 Q4	$13K	Hold	117	–	–	﹤0.01%	1271
2018 Q3	$15K	Hold	117	–	–	﹤0.01%	1268
2018 Q2	$13K	Hold	117	–	–	﹤0.01%	1289
2018 Q1	$12K	Hold	117	–	–	﹤0.01%	1283
2017 Q4	$13	Buy	+117	New	+$12.7K	﹤0.01%	1244

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Private Capital Group's CRL Position: Q2 2022 in Review

Private Capital Group held its Charles River Laboratories (CRL) position steady in Q2 2022 at 97 shares worth $21K. The position accounts for 0.02% of the portfolio, ranked #807.

Private Capital Group first reported a position in CRL in Q4 2017 and has held it in 19 quarters since. The position peaked at $45K in Q4 2020. 628 funds tracked by Wall St. Rank hold CRL as of Q2 2022.

Private Capital Group held 97 shares of Charles River Laboratories worth $21K as of Q2 2022.
Private Capital Group left its Charles River Laboratories share count unchanged in Q2 2022.
Charles River Laboratories made up 0.02% of Private Capital Group's portfolio in Q2 2022, its #807 holding.
Private Capital Group first reported a position in Charles River Laboratories in Q4 2017 and has held it in 19 quarters since.
Private Capital Group's Charles River Laboratories position peaked at $45K in Q4 2020.
628 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.